努辛森改善了2型和3型脊柱肌肉缩患者的运动功能
Bogdana Cavaloiu1,2, Iulia-Elena Simina3, Crisanda Vilciu4,5
1Faculty of Medicine, Department of Microscopic Morphology, Genetics Discipline, Center of Genomic Medicine, 'Victor Babes' University of Medicine and Pharmacy Timisoara, 2 E. Murgu, Sq., 300041 Timisoara, Romania.
Biomedicines
|August 29, 2024
概括
在54个月的时间里,努辛森治疗显著改善了脊髓肌肉缩 (SMA) 2型和3型患者的运动功能. 在SMA Type 3中显著改善,年龄和遗传学等因素影响了结果.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊柱肌缩 (SMA) 是一种由SMN1基因突变引起的遗传神经肌肉疾病.
- 运动神经元退化导致肌肉逐渐衰弱和缩.
- 努辛森是一种经批准的治疗方法,向SMN基因表达,以改善运动功能.
研究的目的:
- 为了评估nusinersen在SMA类型2和3患者的运动技能上的实际有效性.
- 在54个月的时间内分析运动功能的变化.
- 为了确定治疗反应的预测因素.
主要方法:
- 对37名SMA患者进行前性纵向研究,这些患者接受了nusinersen治疗.
- 使用修订的上肢模块量表 (RULM) 和哈默斯密功能运动量表扩展 (HFMSE) 评估运动技能.
- 使用R软件进行的统计分析,包括通用估计方程 (GEE).
主要成果:
- 在运动功能得分 (RULM,HFMSE) 中观察到显著改善.
- 3型SMA患者表现出特别显著的增长.
- GEE确定了时间,SMA类型,患者年龄和外细胞缺失作为运动得分改善的显著预测因素.
结论:
- 努辛森在SMA类型2和3的现实环境中证明了改善运动功能的有效性.
- 患者特异性因素 (遗传学,年龄,SMA类型) 影响治疗反应.
- 个性化治疗策略对于优化SMA的结果至关重要.
关键词:
在HFMSE中使用.统治 统治 统治在SMA中,SMA就是SMA.一个SMN1的SMN1基因表达的基因表达方式遗传性疾病是一种遗传性疾病.运动功能 运动功能 运动功能突变是一种突变.没有任何的 nusinersenersen.里斯迪普拉姆的风险脊柱肌肉缩 脊柱肌肉缩 脊柱肌肉缩针对性治疗的目标治疗.更多相关视频
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
60.6K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.6K
相关概念视频
01:24Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
01:21Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K